Skip to main content
SpringerLink
Log in

Practical Approaches to Promote Adherence and Improve Blood Pressure Control in Black Patients

  • Chapter
  • First Online:
Hypertension in High Risk African Americans

Part of the book series: Clinical Hypertension and Vascular Diseases ((CHVD))

  • 682 Accesses

Abstract

Patient adherence to recommended therapy is a key factor in addressing the disparities in blood pressure control rates and hypertension-related complications between blacks and whites. Poor adherence to long-term therapy results in failure to achieve blood pressure targets, exacerbations of disease, increased hospitalizations and emergency department visits, adverse health outcomes, and increased preventable health care costs. Developing strategies to increase adherence, and ultimately improve blood pressure control rates and outcomes, requires an understanding of the complex interplay of the behavioral factors and belief systems that effect how patients interact with the health care system.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sabate E, et al. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.

    Google Scholar 

  2. Hill MN, Miller NH, DeGeest S, American Society of Hypertension Writing Group. ASH position paper: adherence and persistence with taking medication to control high blood pressure. J Clin Hypertens (Greenwich). 2010;12:757–64.

    Article  Google Scholar 

  3. Go AS, Mozaffarian D, Roger VL, American Heart Association Statistics Committee and Stroke Statistics Subcommittee, et al. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127:e6–245.

    Article  PubMed  Google Scholar 

  4. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303(20):2043–50.

    Article  CAS  PubMed  Google Scholar 

  5. Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs. Lancet. 2000;356:1955–64.

    Article  CAS  PubMed  Google Scholar 

  6. Holmes HM, Luo R, Hanlon JT, et al. Ethnic disparities in adherence to antihypertensive medications of medicare part D beneficiaries. J Am Geriatr Soc. 2012;60(7):1298–303.

    Article  PubMed Central  PubMed  Google Scholar 

  7. McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348(26):2635–45.

    Article  PubMed  Google Scholar 

  8. Vrijens B, Vincze G, Kristano P, et al. Adherence to prescribed anti-hypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ. 2008;336:1114–7.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Mapes RE. Physician’s drug innovation and relinquishment. Soc Sci Med. 1977;11:619–24.

    Article  CAS  PubMed  Google Scholar 

  10. Flack JM, Novikov SV, Ferrario CM. Benefits of adherence to antihypertensive drug therapy. Eur Heart J. 1996;17:16–20.

    Article  PubMed  Google Scholar 

  11. McHorney CA, Gadkari AS. Individual patients hold different beliefs to prescription medications to which they persist and nonpersist and persist vs nonfulfill. Patient Prefer Adherence. 2010;4:187–95.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Haynes RB, Taylor DW, Sackert DL, editors. Compliance in health care. Baltimore: Johns Hopkins University Press; 1979.

    Google Scholar 

  13. Vawter L, Tong X, Gemilyan M, et al. Barriers to antihypertensive medication adherence among adults—United States. J Clin Hypertens (Greenwich). 2005;10((12)):922–9.

    Google Scholar 

  14. Viswanathan M, Golin CE, Jones CD, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med. 2012;157(11):785–95.

    Article  PubMed  Google Scholar 

  15. Cherry SB, Benner JS, Ma H. The clinical and economic burden of nonadherence with antihypertensive and lipid lowering therapy in hypertensive patients. Value Health. 2009;12:489–97.

    Article  PubMed  Google Scholar 

  16. Douglas JG, Bakris GL, Epstein M, et al. Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med. 2003;163(5):525–41.

    Article  PubMed  Google Scholar 

  17. Ishisaka DY, Jukes T, Romanelli RJ, et al. Disparities in adherence to and persistence with antihypertensive regimens: an exploratory analysis from a community-based provider network. J Am Soc Hypertens. 2012;6(3):201–9.

    Article  PubMed  Google Scholar 

  18. Grigoryan L, Pavlik VN, Hyman DJ. Predictors of antihypertensive medication adherence in two urban health-care systems. Am J Hypertens. 2012;25(7):735–8.

    Article  PubMed  Google Scholar 

  19. Holt E, Joyce C, Dornelies A, et al. Sex differences in barriers to antihypertensive medication adherence: findings from the cohort study of medication adherence among older adults. J Am Geriatr Soc. 2013;61(4):558–64.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Bosworth HB, Dudley T, Olsen MK, et al. Racial differences in blood pressure control: potential explanatory factors. Am J Med. 2006;119:70.e9–15.

    Google Scholar 

  21. Lewis LM. Patient factors, but not provider and health care system factors, predict medication adherence in hypertensive black men. J Clin Hypertens (Greenwich). 2012;14(4):250–5.

    Article  Google Scholar 

  22. Lewis LM, Ogedegbe C, Ogedegbe G. Enhancing adherence of antihypertensive regimens in hypertensive African-Americans: current and future prospects. Expert Rev Cardiovasc Ther. 2012;10(11):1375–80.

    Article  CAS  PubMed  Google Scholar 

  23. Braverman J, Dedier J. Predictors of medication adherence for African-American patients diagnosed with hypertension. Ethn Dis. 2009;19(4):396–400.

    PubMed  Google Scholar 

  24. Many US adults fail to take prescription drugs as prescribed. http://online.wsj.com/article/0,,SB111202967075490978,00.html. Accessed 24 Jan 2014.

  25. Schoenthaler A, Ogedegbe G, Allegrante JP. Self-efficacy mediates the relationship between depressive symptoms and medication adherence among hypertensive African Americans. Health Educ Behav. 2009;36(1):127–37.

    Article  PubMed  Google Scholar 

  26. Elder K, Ramamonjiarivelo Z, Wiltshire J, et al. Trust, medication adherence, and hypertension control in Southern African American me. Am J Public Health. 2012;102(12):2242–5.

    Article  PubMed Central  PubMed  Google Scholar 

  27. Brown CM, Segal R. Ethnic differences in temporal orientation and its implications for hypertension management. J Health Soc Behav. 1996;37:350–61.

    Article  CAS  PubMed  Google Scholar 

  28. Krousel-Wood MA, Munter P, Joyce CJ, et al. Adverse effects of complementary and alternative medicine on antihypertensive medication adherence: findings from the cohort study of medication adherence among older adults. J Am Geriatr Soc. 2010;58:54–61.

    Article  PubMed Central  PubMed  Google Scholar 

  29. Agarwal B, Mosca L. Lifestyle and psychosocial risk factors predict non-adherence to medication. Ann Behav Med. 2010;40:228–33.

    Article  Google Scholar 

  30. Carmody TP, Fey SG, Pierce DK, et al. Behavioral treatment of hyperlipidemia: techniques, results, and future directions. J Behav Med. 1982;5(1):91–116.

    Article  CAS  PubMed  Google Scholar 

  31. Cene CW, Dennison CR, Powell Hammond W, et al. Antihypertensive medication nonadherence in black men: direct and mediating effects of depressive symptoms, psychosocial stressors, and substance abuse. J Clin Hypertens (Greenwich). 2013;15(3):201–9.

    Article  Google Scholar 

  32. AlGhurair SA, Hughes CA, Simpson SH, et al. A systematic review of patient self-reported barriers of adherence to antihypertensive medications using the WHO multidimensional adherence model. J Clin Hypertens (Greenwich). 2012;14(12):877–86.

    Article  Google Scholar 

  33. Martin MY, Kohler C, Kim YI, et al. Taking less than prescribed: medication nonadherence and provider-patient relationships in lower-income, rural minority adults with hypertension. J Clin Hypertens (Greenwich). 2010;12(9):706–13.

    Article  Google Scholar 

  34. Gamble VN. Under the shadow of Tuskegee: African Americans and health care. Am J Public Health. 1997;87:1773–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  35. Choudry NK, Avorn J, Glynn RJ, et al. Post-myocardial infarction free RX event and economic evaluation (MI FREEE) trial. Full coverage for preventive medications after myocardial infarction. N Engl J Med. 2011;365:2088–97.

    Article  Google Scholar 

  36. Heisler M, Hofer TP, Schmittdiel JA, et al. Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high-performing health systems: the adherence and intensification of medications cluster randomized, controlled pragmatic trial. Circulation. 2012;125:2863–72.

    Article  PubMed Central  PubMed  Google Scholar 

  37. Turner BJ, Hollenbeak C, Weiner MG, et al. Barriers to adherence and hypertension control in a racially diverse representative sample of elderly primary care patients. Pharmacoepidemiol Drug Saf. 2009;18(8):672–81.

    Article  PubMed  Google Scholar 

  38. Li P, McElligott S, Bergquist H, Schwartz JS, et al. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia. Ann Intern Med. 2012;156(11):776–84.

    Article  PubMed  Google Scholar 

  39. Guide to Community Preventive Services. Cardiovascular disease prevention and control: reducing out-of-pocket costs for cardiovascular disease preventive services for patients with high blood pressure and high cholesterol. www.thecommunityguide.org/cvd/ROPC.html. Accessed 25 Aug 2013.

  40. Farley JF, Wansink D, Lindquist JH, et al. Medication adherence changes following value-based insurance design. Am J Manag Care. 2012;18(5):265–74.

    PubMed  Google Scholar 

  41. Fendrick AM, Smith DG, Chernew ME, et al. A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost. Am J Manag Care. 2001;7(9):861–7.

    CAS  PubMed  Google Scholar 

  42. Chernew ME, Rosen AB, Fendrick AM. Value-based insurance design. Health Aff (Millwood). 2007;26(2):W195–203.

    Article  Google Scholar 

  43. Chernew ME, Juster IA, Shah M, et al. Evidence that value-based insurance can be effective. Health Aff (Millwood). 2010;29(3):530–6.

    Article  Google Scholar 

  44. Gibson TB, Wang S, Kelly E, et al. A value-based insurance design program at a large company boosted medication adherence for employees with chronic illness. Health Aff (Millwood). 2011;30(1):109–17.

    Article  Google Scholar 

  45. Wagner EH, Davis C, Schaefer J, et al. A survey of leading chronic disease management programs: are they consistent with the literature? Manag Care Q. 1999;7(3):56–66.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiovascular Division, Department of Internal Medicine, Washington University School of Medicine, 660 South Euclid, Box 8086, St. Louis, MO, 63110, USA

    Angela L. Brown M.D.

  2. Medical & Academic Affairs, Jersey Shore University Medical Center, Neptune, NJ, USA

    David Kountz M.D.

Authors
  1. Angela L. Brown M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Kountz M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Angela L. Brown M.D. .

Editor information

Editors and Affiliations

  1. Cardiology, Tulane University School of Medicine, New Orleans, Louisiana, USA

    Keith C. Ferdinand

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Brown, A.L., Kountz, D. (2015). Practical Approaches to Promote Adherence and Improve Blood Pressure Control in Black Patients. In: Ferdinand, K. (eds) Hypertension in High Risk African Americans. Clinical Hypertension and Vascular Diseases. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2010-5_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2010-5_12

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-2009-9

  • Online ISBN: 978-1-4939-2010-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation